Results
|
2281.
|
|
|
2282.
|
|
|
2283.
|
Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients. [electronic resource] by
- Cakirca, Mustafa
- Karatoprak, Cumali
- Zorlu, Mehmet
- Kiskac, Muharrem
- Kanat, Mustafa
- Cikrikcioglu, Mehmet Ali
- Soysal, Pinar
- Hursitoglu, Mehmet
- Camli, Ahmet Adil
- Erkoc, Reha
- Abdul-Ghani, Muhammad
Producer: 20141124
In:
Drug design, development and therapy vol. 8
Availability: No items available.
|
|
2284.
|
|
|
2285.
|
Protective Effects of Vildagliptin against Pioglitazone-Induced Bone Loss in Type 2 Diabetic Rats. [electronic resource] by
- Eom, Young Sil
- Gwon, A-Ryeong
- Kwak, Kyung Min
- Kim, Ju-Young
- Yu, Seung Hee
- Lee, Sihoon
- Kim, Yeun Sun
- Park, Ie Byung
- Kim, Kwang-Won
- Lee, Kiyoung
- Kim, Byung-Joon
Producer: 20170630
In:
PloS one vol. 11
Availability: No items available.
|
|
2286.
|
Saxagliptin alters bile acid profiles and yields metabolic benefits in drug-naïve overweight or obese type 2 diabetes patient. [electronic resource] by
- Li, Wen
- Liu, Ruixin
- Li, Xuelin
- Tao, Bei
- Zhai, Nan
- Wang, Xiaolin
- Li, Qi
- Zhang, Yifei
- Gu, Weiqiong
- Wang, Weiqing
- Ning, Guang
Producer: 20200421
In:
Journal of diabetes vol. 11
Availability: No items available.
|
|
2287.
|
|
|
2288.
|
|
|
2289.
|
|
|
2290.
|
|
|
2291.
|
|
|
2292.
|
|
|
2293.
|
|
|
2294.
|
|
|
2295.
|
CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice. [electronic resource] by
- Yan, Liping
- Hu, Xiangnan
- Wu, Qihong
- Jiang, Rong
- Zhang, Sisi
- Ling, Qiao
- Liu, Hailin
- Jiang, Xuejun
- Wan, Jingyuan
- Liu, Yingju
Producer: 20180326
In:
International immunopharmacology vol. 47
Availability: No items available.
|
|
2296.
|
|
|
2297.
|
|
|
2298.
|
|
|
2299.
|
|
|
2300.
|
|